Intestinal epithelial and mucin surfaces

The intestinal epithelial and mucin surfaces constitute a multi-layered barrier essential for maintaining gastrointestinal homeostasis and systemic health (Vancamelbeke & Vermeire, 2017). This interface consists of a cellular layer of enterocytes and specialized cells, such as goblet cells, which secrete mucins (primarily MUC2) to form a protective gel-like matrix (Johansson & Hansson, 2016). Its primary biological functions include the selective absorption of nutrients and the exclusion of luminal pathogens and toxins, a process regulated by tight junction proteins (Okumura & Takeda, 2017). Dysfunction of this surface is a hallmark of various pathologies, including inflammatory bowel disease (IBD), celiac disease, and "leaky gut" syndromes, where increased permeability triggers immune activation (Chelakkot et al., 2018). Therapeutic interventions targeting this area often involve mucosal protectants, probiotics, or drugs like linaclotide that modulate surface receptors to treat functional GI disorders (Blackshaw et al., 2011). Additionally, the mucin layer serves as a habitat for the commensal microbiota, which in turn influences the integrity and function of the underlying epithelium (Paone & Cani, 2020). Drugs interacting with this surface may act through physical coating, chemical neutralization, or by stimulating endogenous repair mechanisms to restore barrier integrity (Turner, 2009).

Other names

Intestinal mucosal barrierGut barrierIntestinal mucosaMucus-epithelial interfaceIntestinal lining

Drugs targeting this surface typically act by providing a physical protective coating, enhancing the integrity of tight junctions, or modulating local receptors on the epithelial cell membrane to alter fluid secretion, motility, and inflammatory signaling.